iBio
IBIO
#10069
Rank
NZ$0.13 B
Marketcap
NZ$2.07
Share price
0.00%
Change (1 day)
42.68%
Change (1 year)

iBio (IBIO) - Cash on Hand

Cash on Hand as of June 2026 : NZ$0.15 Billion

According to iBio's latest financial reports the company has NZ$0.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

iBio - Cash on Hand chart (from 2008 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-06-30NZ$14.08 M-39.54%
2024-06-30NZ$23.29 M232.25%
2023-06-30NZ$7.01 M-86.95%
2022-06-30NZ$53.71 M-61.24%
2021-06-30NZ$0.13 B62.24%
2020-06-30NZ$85.43 M1199.17%
2019-06-30NZ$6.57 M-72.05%
2018-06-30NZ$23.52 M112.98%
2017-06-30NZ$11.04 M-65.74%
2016-06-30NZ$32.24 M130.54%
2015-06-30NZ$13.98 M241.44%
2014-06-30NZ$4.09 M-28.18%
2013-06-30NZ$5.7 M-18.6%
2012-06-30NZ$7 M104.17%
2011-06-30NZ$3.43 M160.92%
2010-06-30NZ$1.31 M-18.85%
2009-06-30NZ$1.62 M6388.84%
2008-06-30NZ$0.02 M1.95%
2007-06-30NZ$0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$36.77 B 23,478.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ$35.67 M-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$1.21 B 677.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.24 B 58.68%๐Ÿ‡บ๐Ÿ‡ธ USA